Latest Radiopharmacology Stories
SAINT-GENIS-POUILLY, France, April 29, 2014 /PRNewswire/ -- Advanced Accelerator Applications S.A.
Lumiphore Inc., a pharmaceutical leader in bifunctional chelator design, is developing in vivo radio-diagnostic imaging and site-directed radio-therapeutics, using its proprietary bifunctional radionuclide
Two-part webinar to highlight benefits of molecular imaging in drug development MATTAWAN, Mich., April 15, 2014 /PRNewswire/ -- MPI Research and Translational Imaging Center partners,
MONTREAL, April 9, 2014 /PRNewswire/ - Jubilant DraxImage Inc., a Jubilant Life Sciences Company, is pleased to announce the appointment of Mr.
DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c3vlm5/global) has announced the addition of the "Global Radiopharmaceuticals
RnRMarketResearch.com adds Latest Report on “Global Radiopharmaceuticals Market Insight” to its store. Dallas, TX (PRWEB) March 23, 2014 “Purchase
BERLIN and BOSTON, March 20, 2014 /PRNewswire/ -- Piramal Imaging today announced that the U.S. Food and Drug Administration (FDA) has approved Neuraceq(TM).
Opportunities for developments, mergers and acquisitions, and investments are just ahead. Louvain-la-Neuve, Belgium, and Lalaye, France (PRWEB) March 13, 2014
SAINT-GENIS-POUILLY, France, March 4, 2014 /PRNewswire/ -- Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM),
- The act of sweetening by admixture of some saccharine substance.